A

AmMax Bio., Inc.

8 employees

AmMax unlocks the therapeutic service's potential on the CSF1R platform.

Basic info

Industry

pharmaceutical manufacturing

Sectors

oncology and TGCT
Biotechnology
Pharmaceutical

Date founded

2020

Funding rounds raised

A

AmMax Bio., Inc. raised undisclosed on August 15, 2022

Investors: Taiwania Capital

FAQ